Elevated ANXA1 mRNA expression was found in dasatinib sensitive breast and ovarian cell lines [11, 15], whilst EphA2 mRNA was elevated in breast, ovarian and prostate cancer cell lines [11, 14, 15]. Here, ANXA1 is linked to prostate carcinoma.